PMID- 21352788 OWN - NLM STAT- MEDLINE DCOM- 20110705 LR - 20220409 IS - 1878-0067 (Electronic) IS - 1755-4365 (Print) IS - 1878-0067 (Linking) VI - 2 IP - 4 DP - 2010 Dec TI - HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. PG - 173-82 LID - 10.1016/j.epidem.2010.08.003 [doi] AB - BACKGROUND: HIV prevalence is low in the Middle East and North Africa (MENA) region, though the risk or potential for further spread in the future is not well understood. Behavioral surveys are limited in this region and when available have serious limitations in assessing the risk of HIV acquisition. We demonstrate the potential use of herpes simplex virus-2 (HSV-2) seroprevalence as a marker for HIV risk within MENA. METHODS: We designed a mathematical model to assess whether HSV-2 prevalence can be predictive of future HIV spread. We also conducted a systematic literature review of HSV-2 seroprevalence studies within MENA. RESULTS: We found that HSV-2 prevalence data are rather limited in this region. Prevalence is typically low among the general population but high in established core groups prone to sexually transmitted infections such as men who have sex with men and female sex workers. Our model predicts that if HSV-2 prevalence is low and stable, then the risk of future HIV epidemics is low. However, expanding or high HSV-2 prevalence (greater than about 20%), implies a risk for a considerable HIV epidemic. Based on available HSV-2 prevalence data, it is not likely that the general population in MENA is experiencing or will experience such a considerable HIV epidemic. Nevertheless, the risk for concentrated HIV epidemics among several high-risk core groups is present. CONCLUSIONS: HSV-2 prevalence surveys provide a useful mechanism for identifying and corroborating populations at risk for HIV within MENA. HSV-2 serology offers an effective tool for probing hidden sexual risk behaviors in a region where quality behavioral data are limited. CI - Copyright (c) 2010 Elsevier B.V. All rights reserved. FAU - Abu-Raddad, Laith J AU - Abu-Raddad LJ AD - Infectious Disease Epidemiology Group, Weill Cornell Medical College-Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar. lja2002@qatar-med.cornell.edu FAU - Schiffer, Joshua T AU - Schiffer JT FAU - Ashley, Rhoda AU - Ashley R FAU - Mumtaz, Ghina AU - Mumtaz G FAU - Alsallaq, Ramzi A AU - Alsallaq RA FAU - Akala, Francisca Ayodeji AU - Akala FA FAU - Semini, Iris AU - Semini I FAU - Riedner, Gabriele AU - Riedner G FAU - Wilson, David AU - Wilson D LA - eng GR - K23 AI087206/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review PT - Systematic Review DEP - 20100915 PL - Netherlands TA - Epidemics JT - Epidemics JID - 101484711 SB - IM MH - Africa, Northern/epidemiology MH - *Disease Outbreaks MH - Female MH - Forecasting/methods MH - HIV Infections/*epidemiology/transmission/virology MH - HIV-1/isolation & purification MH - Herpes Simplex/*epidemiology/virology MH - Herpesvirus 2, Human/*isolation & purification MH - Homosexuality, Male/statistics & numerical data MH - Humans MH - Male MH - Middle East/epidemiology MH - Models, Biological MH - Population Surveillance/methods MH - Prevalence MH - Seroepidemiologic Studies MH - Unsafe Sex/*statistics & numerical data PMC - PMC3722433 MID - NIHMS471013 EDAT- 2011/03/01 06:00 MHDA- 2011/07/06 06:00 PMCR- 2013/07/25 CRDT- 2011/03/01 06:00 PHST- 2010/01/18 00:00 [received] PHST- 2010/08/26 00:00 [revised] PHST- 2010/08/31 00:00 [accepted] PHST- 2011/03/01 06:00 [entrez] PHST- 2011/03/01 06:00 [pubmed] PHST- 2011/07/06 06:00 [medline] PHST- 2013/07/25 00:00 [pmc-release] AID - S1755-4365(10)00059-9 [pii] AID - 10.1016/j.epidem.2010.08.003 [doi] PST - ppublish SO - Epidemics. 2010 Dec;2(4):173-82. doi: 10.1016/j.epidem.2010.08.003. Epub 2010 Sep 15.